<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>healthcare system burden &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/healthcare-system-burden/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 08 Oct 2025 23:16:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>healthcare system burden &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Experts caution that prostate testing may miss targeting those who would benefit most</title>
		<link>https://bioengineer.org/experts-caution-that-prostate-testing-may-miss-targeting-those-who-would-benefit-most/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 08 Oct 2025 23:16:24 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Demographic screening disparities]]></category>
		<category><![CDATA[healthcare system burden]]></category>
		<category><![CDATA[Prostate cancer overtesting]]></category>
		<category><![CDATA[PSA retesting intervals]]></category>
		<category><![CDATA[PSA testing guidelines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/experts-caution-that-prostate-testing-may-miss-targeting-those-who-would-benefit-most/</guid>

					<description><![CDATA[A new comprehensive study conducted in England has cast a critical spotlight on the current practices surrounding prostate specific antigen (PSA) testing, unveiling worrying trends of overtesting and misaligned testing intervals that could have profound implications for men’s health and healthcare systems. This landmark observational study, published in The BMJ, evaluated data from over 10 [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">277845</post-id>	</item>
		<item>
		<title>Healthcare Costs of ADHD-Related Adverse Events</title>
		<link>https://bioengineer.org/healthcare-costs-of-adhd-related-adverse-events/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Sep 2025 11:58:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ADHD adverse events]]></category>
		<category><![CDATA[claims-based study]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[healthcare system burden]]></category>
		<category><![CDATA[pediatric patients]]></category>
		<guid isPermaLink="false">https://bioengineer.org/healthcare-costs-of-adhd-related-adverse-events/</guid>

					<description><![CDATA[In a groundbreaking study published in Advances in Therapy, researchers led by Schein et al. reveal the staggering healthcare costs associated with adverse events in pediatric patients diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). The study, leveraging extensive claims data, highlights a critical and often overlooked aspect of ADHD management — the economic burden that adverse events [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">268689</post-id>	</item>
	</channel>
</rss>
